The new-look syringes are causing significant issues when used with syringe infusion pumps. This is a Class I recall, which means the FDA believes the products “may cause serious injuries or death.”

He has agreed to pay an administrative fee of $1,100 within the next three months.

“We cannot emphasize strongly enough the depths of the departments’ failure," 25 members of the Ways & Means Committee wrote recently.

The product integrates into other modules that detect a variety of emergency conditions affecting the brain, including aneurysm and stroke.

BlackSuit has “significant similarities” to the Royal ransomware family, a direct successor of the “notorious” Russian-linked Conti operation, the agency reported. 

ACR, the American Society of Neuroradiology and the Society of Interventional Radiology voiced their concerns in a recent letter to leaders in the U.S. House and Senate. 

“Nearly 300,000 cardiac arrests occur in hospitals in the United States each year, and only about 25% of people survive to hospital discharge after these types of events,” according to one author of a new analysis published in Circulation: Cardiovascular Quality and Outcomes.

One key difference between this new risk calculator and previous methods is that it does not consider a patient's race or ethnicity. It does, however, consider such factors as where the patient lives, their education and their income level.